Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

The U.S. Food and Drug Administration approved PTC Therapeutics' gene therapy that is administered directly in the brain to ...

Analysts expect PTC to report an earnings per share (EPS) of $1.45. PTC bulls will hope to hear the company announce they've ...

Founded in 1985, PTC has 28,000 customers, with revenue stemming mostly from North America (45%) and Europe (40%). Market Capitalization: Indicating a reduced size compared to industry averages ...

This means it is expected to impact land within the next 48 hours, and even though it hasn’t fully developed yet, advisories ...

PTC 19 is expected to become Tropical Storm Sara sometime Thursday as it moves toward Central America. Sara will get caught between ... As of right now, it looks like no direct impacts are expected to ...

Analyst Jeffrey Hung of Morgan Stanley maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), retaining the price target ...

Panellists were announced during annual conference for The Personal Travel Consultants in Partnership with Blue Bay Travel, ...

This collaboration will integrate Configit's Configuration Lifecycle Management (CLM) solutions with PTC's Product Lifecycle Management (PLM) systems, offering a comprehensive and cohesive ...

WARREN, N.J., Oct. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 23, 2024, the company approved non-statutory stock options to purchase an aggregate ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth-quarter conference call. (Operator Instructions) I would now like to turn the call over to ...

Q4 2024 Earnings Conference Call November 6, 2024 5:00 PM ETCompany ParticipantsMatt Shimao - Head of Investor RelationsNeil Barua ...